[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Q32 Bio Inc (QTTB)

Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Q32 Bio Inc 830 WINTER STREET WALTHAM MA 02451 USA

www.q32bio.com Employees: 24 P: 781-999-0232

Sector:

Medical

Description:

Q32 Bio Inc. is a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis. Q32 Bio Inc., formerly known as Homology Medicines Inc., is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 93,258
Enterprise Value, $K 54,668
Shares Outstanding, K 16,956
Float, K 10,174
% Float 60.00%
Short Interest, K 653
Short Float 3.85%
Days to Cover 1.65
Short Volume Ratio 0.48
% of Insider Shareholders 40.00%
% of Institutional Shareholders 31.32%

Financials:

Annual Sales, $ 53,740 K
Annual Net Income, $ 29,820 K
Last Quarter Sales, $ 53,740 K
Last Quarter Net Income, $ 57,730 K
EBIT, $ -36,840 K
EBITDA, $ -36,270 K

Growth:

1-Year Return 271.21%
3-Year Return -70.04%
5-Year Return -95.40%
5-Year Revenue Growth 1,890.37%
5-Year Earnings Growth 102.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 05/05/26
Next Earnings Date 08/05/26
Earnings Per Share ttm 1.37
EPS Growth vs. Prev Qtr -114.79%
EPS Growth vs. Prev Year 40.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 03/26/24

QTTB Ratios

Ratio
Price/Earnings ttm 3.28
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 149.23%
Return-on-Assets % 34.50%
Profit Margin % 55.49%
Debt/Equity 0.23
Price/Sales 1.79
Price/Cash Flow 3.74
Price/Book 1.91
Book Value/Share 3.42
Interest Coverage 2.69
60-Month Beta -0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.